responder

Public:

imprimir

marcas esta publicación como favorita Global Oral Vaccines market research (Tianhe District, Guangzhou, Guangdong Province, China) ocultar esta publicación desocultar

Global Oral Vaccines market will reach 3480 million US$ by the end of 2025

Publisher: QYResearch
Published Date: 2018/11/6

Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.

Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.

In the last several years, global market of oral vaccines developed rapidly, with an average growth rate of 6.31%. In 2017, global revenue of oral vaccines is nearly 2.01 billion USD; the actual consumption is about 2.2 billion doses.

The classification of oral vaccines includes rotavirus vaccine, cholera vaccine, oral polio vaccine and other types, and the sales proportion of polio vaccine in 2017 is about 94%, and the proportion is in decreasing trend from 2012 to 2017.

The global Oral Vaccines market is valued at 2010 million US$ in 2017 and will reach 3480 million US$ by the end of 2025, growing at a CAGR of 7.1% during 2018-2025.

This article was first released by QYResearch, if reproduced, please indicate the source.
  • puedes contactar al dueño del anuncio con servicios o intereses comerciales

Id public: 6741925943

Public:

Mejor de [?]